×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.

ADNI is currently accepting Letters of Intent to submit proposals concerning biomarkers or other assessment tools Read more

Alzheimer’s Disease Neuroimaging Initiative

WATCH VIDEO

Sharing Alzheimer’s research
data with the world

Welcome

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease (AD). ADNI researchers collect, validate and utilize data, including MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors of the disease. Study resources and data from the North American ADNI study are available through this website, including Alzheimer’s disease patients, mild cognitive impairment subjects, and elderly controls.

Click below to learn more or to join the ADNI study as a participant.

LEARN MORE

Returning users

Welcome to the new website with added content for ADNI3. The site builds upon the ADNI1, ADNI-GO, and ADNI2 studies, public-private collaborations aimed at determining the relationships between clinical, cognitive, imaging, genetic, and biochemical biomarkers across the entire spectrum of Alzheimer’s disease. ADNI3 will continue efforts to discover, optimize, standardize, and validate clinical trial measures and biomarkers used in AD clinical research.

Please comment on the website here.

ADNI 3 STUDY
×